Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.01-0617fjePMID 11790725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation

  2001influential reference
• Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• Dynamic Shuttling of Nuclear Factor κB between the Nucleus and Cytoplasm as a Consequence of Inhibitor Dissociation*

  2000cited by this paper
• MDM2-dependent ubiquitination of nuclear and cytoplasmic P53

  2000cited by this paper
• A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.

  2000cited by this paper
• Death Signal-induced Localization of p53 Protein to Mitochondria

  2000cited by this paper
• An intact HDM2 RING-finger domain is required for nuclear exclusion of p53

  2000influential reference
• Regulated Nuclear-Cytoplasmic Localization of Interferon Regulatory Factor 3, a Subunit of Double-Stranded RNA-Activated Factor 1

  2000cited by this paper
• The MDM2 RING-finger domain is required to promote p53 nuclear export

  2000influential reference
• Intracellular targeting of the proteasome.

  2000cited by this paper
• Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

  2000cited by this paper
• A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

  1999cited by this paper
• Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region.

  1999cited by this paper
• An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.

  1999cited by this paper
• The p53 pathway

  1999cited by this paper
• Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.

  1999cited by this paper
• Putative Reaction Intermediates in Crm1-mediated Nuclear Protein Export*

  1999cited by this paper
• Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation

  1999cited by this paper
• Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

  1998influential reference
• Transport into and out of the cell nucleus

  1998cited by this paper
• The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells*

  1998cited by this paper
• Mdm2 association with p53 targets its ubiquitination

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998influential reference
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• Dynamics of proteasome distribution in living cells

  1997influential reference
• Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

  1997cited by this paper
• CRM1 is an export receptor for leucine-rich nuclear export signals.

  1997influential reference
• Evidence for a role of CRM1 in signal-mediated nuclear protein export.

  1997cited by this paper
• Exportin 1 (Crm1p) is an essential nuclear export factor.

  1997cited by this paper
• CRM1 is responsible for intracellular transport mediated by the nuclear export signal

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997influential reference
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage

  1996cited by this paper
• Overexpression of the MDM2 oncogene in leukemia and lymphoma.

  1996cited by this paper
• Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol.

  1996cited by this paper
• Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding

  1995influential reference
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

  1995cited by this paper
• Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression.

  1994cited by this paper
• Changes in proteasome localization during the cell cycle.

  1994cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• Effects of leptomycin B on the cell cycle of fibroblasts and fission yeast cells.

  1990cited by this paper

• Nucleolus as a cornerstone linking proliferation and metabolism to cellular responses to stress: involvement of transcription factors MYC and p53.

  2026cites this paper
• Discovery of Potent HDAC6-Selective Inhibitors Based on Artemisinin: Design, Synthesis, and Antitumor Evaluation.

  2026cites this paper
• Harnessing p53 for targeted cancer therapy: new advances and future directions

  2025cites this paper
• Nucleo-cytoplasmic environment modulates spatiotemporal p53 phase separation

  2024cites this paper
• Comparative Expression Analysis of TP53 Tumor Suppressor and MDM2 Oncogene in Colorectal Adenocarcinoma.

  2024cites this paper
• Tbl1 promotes Wnt/β-catenin signaling-induced degradation of the Tcf7l1 protein in mouse ESCs.

  2024cites this paper
• TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review)

  2024cites this paper
• p53: From Fundamental Biology to Clinical Applications in Cancer

  2022cites this paper
• EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes.

  2022cites this paper
• p53 Isoforms as Cancer Biomarkers and Therapeutic Targets

  2022cites this paper
• Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.

  2021cites this paper
• Measuring cell cycle-dependent DNA damage responses and p53 regulation on a cell-by-cell basis from image analysis

  2018cites this paper
• Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status.

  2018cites this paper
• Tumor suppressor RYBP harbors three nuclear localization signals and its cytoplasm-located mutant exerts more potent anti-cancer activities than corresponding wild type.

  2017cites this paper
• Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways

  2016cites this paper
• Molekularne podstawy komórkowego starzenia: fenomen Hayflicka 50 lat później* Molecular bases of cellular senescence: Hayflick phenomenon 50 years later

  2016cites this paper
• Differential transcript accumulation and subcellular localization of Arabidopsis ribosomal proteins.

  2014cites this paper
• The ubiquitin pathway in host-parasite interactions during infection by Trichinella spiralis

  2014cites this paper
• p53 and ribosome biogenesis stress: The essentials

  2014cites this paper
• Wpływ procesu starzenia się ludzkiego mezotelium otrzewnowego na wykładniki progresji raka jajnika w modelu komórkowym i zwierzęcym

  2014cites this paper
• GRK2 as new onco-modulator of breast tumoural transformation through the regulation of the p53/Mdm2 axis

  2014cites this paper
• Vliv exogenních látek na expresi proteinu p53 u vybraných nádorových linií

  2013cites this paper
• Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.

  2013cites this paper
• Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy

  2013cites this paper
• Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65

  2012cites this paper
• Simulating Molecular Mechanisms of the MDM2-Mediated Regulatory Interactions: A Conformational Selection Model of the MDM2 Lid Dynamics

  2012cites this paper
• Calcium fructoborate: plant-based dietary boron as potential medicine for cancer therapy.

  2011cites this paper
• Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus

  2011cites this paper
• The Fbw7 Tumor Suppressor Regulates Nuclear Factor E2-related Factor 1 Transcription Factor Turnover through Proteasome-mediated Proteolysis*

  2011cites this paper
• Impact of Mdm2-p53 on the proteasome assembly and disassembly Role of the ubiquitination of some 19S subunits

  2011cites this paper
• E3 ubiquitin ligase Hades negatively regulates the exonuclear function of p53

  2011cites this paper
• A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation

  2011cites this paper
• Characterization of regulation of expression and nuclear/nucleolar localization of Arabidopsis ribsomal proteins

  2011cites this paper
• Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress

  2011cites this paper
• Pharmacoproteomic Analysis of a Novel Cell-permeable Peptide Inhibitor of Tumor-induced Angiogenesis*

  2011cites this paper
• Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.

  2010cites this paper
• USP10 regulates p53 localization and stability by deubiquitinating p53.

  2010cites this paper
• Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding

  2010cites this paper
• Harmonic oscillations in homeostatic controllers: Dynamics of the p53 regulatory system.

  2010cites this paper
• p53 stabilization: the importance of nuclear import

  2010cites this paper
• Overexpression of hepatocyte nuclear factor‐3α induces apoptosis through the upregulation and accumulation of cytoplasmic p53 in prostate cancer cells

  2010cites this paper
• Inhibition of HIF prolyl 4-hydroxylases protect endothelial cells from apoptosis INAUGURAL

  2010cites this paper
• A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance in Ataxia Telangiectasia and Nijmegen Breakage Syndrome T-cells.

  2010cites this paper
• A TATA-kötő fehérje asszociált faktor 3 (TAF3) p53-mal való kölcsönhatásának funkcionális vizsgálata

  2010cites this paper
• Cooperation between MDM2 and MDMX in the Regulation of p53

  2010cites this paper
• Lysophosphatidic acid, vitamin D, and p53: a novel signaling axis in cell death and differentiation

  2009cites this paper
• p53 ubiquitination by Mdm2: a never ending tail?

  2009cites this paper
• CAVEOLIN-1 MEDIATED P53 ACTIVATION IN STRESS INDUCED PREMATURE SENESCENCE AND ITS ANTAGONISTIC PLEIOTROPIC IMPLICATIONS IN CANCER

  2009cites this paper
• SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.

  2009cites this paper
• Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval

  2009cites this paper
• CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2

  2008cites this paper
• CARPs enhance p53 turnover by degrading 14-3-3sigma and stabilizing MDM2.

  2008cites this paper
• Tumor Suppressor Opens Gateways for Cancer Therapy

  2008cites this paper
• Proteomic analysis of DNA damage induced stress signaling with focus on p53 : S100A6 regulation, function and potential as biomarker in lung cancer and as a novel therapeutic target

  2008cites this paper
• Comparative Effects of Boric Acid and Calcium Fructoborate on Breast Cancer Cells

  2008cites this paper
• Determining the role of p53 mutation in human breast cancer progression using recombinant mutant/wild-type p53 heterozygous human mammary epithelial cell culture models

  2008cites this paper
• PROTEOMIC ANALYSIS OF DNA DAMAGE INDUCED STRESS SIGNALING WITH FOCUS ON P 53

  2008cites this paper
• Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7

  2008cites this paper
• p53 and DNA damage checkpoint responses in the human prostate

  2007cites this paper
• Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus

  2007cites this paper
• Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma

  2007cites this paper
• PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit

  2007cites this paper
• The Role of Ubiquitination in the Direct Mitochondrial Death Program of p53

  2007cites this paper
• Monoubiquitylation promotes mitochondrial p53 translocation

  2007cites this paper
• Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells

  2007cites this paper
• Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity.

  2007cites this paper
• HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery).

  2007cites this paper
• Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression*

  2007cites this paper
• THE FUNCTIONAL SIGNIFICANCE OF AN ALTERNATELY SPLICED PRODUCT OF THE HDM2 GENE

  2007cites this paper
• Regulation of the P53-MDM2 feedback loop by nucleostemin and ribosomal proteins

  2007cites this paper
• Regulation of tumor suppressor protein p53 in cellular stress and tumorigenesis

  2007cites this paper
• Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX

  2007cites this paper
• The nuclear ubiquitin-proteasome system

  2006influential citation
• Nuclear Accumulations of p53 and Mdm2 are Accompanied by Reductions in c-Abl and p300 in Zinc-Depleted Human Hepatoblastoma Cells

  2006cites this paper
• Role of stress-induced alternative splicing of HDM2 in human tumor and non-tumorigenic cell lines.

  2006cites this paper
• p53 Downregulates Its Activating Vaccinia-Related Kinase 1, Forming a New Autoregulatory Loop

  2006cites this paper
• Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

  2006cites this paper
• p53 ubiquitination: Mdm2 and beyond.

  2006cites this paper
• Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.

  2006cites this paper
• Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta.

  2005cites this paper
• Stress-induced p53 runs a transcription-independent death program.

  2005cites this paper
• Exogenous acid fibroblast growth factor inhibits ischemia-reperfusion-induced damage in intestinal epithelium via regulating P53 and P21WAF-1 expression.

  2005cites this paper
• Involvement of Nuclear Export in Human Papillomavirus Type 18 E6-Mediated Ubiquitination and Degradation of p53

  2005cites this paper
• p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms

  2005cites this paper
• A plausible model for the digital response of p53 to DNA damage.

  2005cites this paper
• Regulation of the MDM2-p53 feedback loop by ribosomal proteins

  2005cites this paper
• Endoplasmic Reticulum Stress Accelerates p53 Degradation by the Cooperative Actions of Hdm2 and Glycogen Synthase Kinase 3β

  2005cites this paper
• The p53 Tumor Suppressor Pathway and Cancer

  2005cites this paper
• Abnormal stability of wild-type p53 protein in a human lung carcinoma cell line.

  2005cites this paper
• Proteasomes degrade proteins in focal subdomains of the human cell nucleus

  2005influential citation
• Cellular UV damage responses--functions of tumor suppressor p53.

  2005cites this paper
• Small molecule antagonists of the MDM2 oncoprotein as anticancer agents.

  2005cites this paper
• ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

  2005cites this paper
• A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation

  2005cites this paper
• Extra Views A New Twist in the Feedback Loop Stress-Activated MDM 2 Destabilization is Required for p 53 Activation

  2005cites this paper
• The p53 paddy wagon: COP1, Pirh2, and MDM2 are found resisting apoptosis and growth arrest

  2004cites this paper
• Human tumor suppressor p53 and DNA viruses

  2004cites this paper
• The neural F-box protein NFB42 mediates the nuclear export of the herpes simplex virus type 1 replication initiator protein (UL9 protein) after viral infection

  2004cites this paper
• Regulation of DNA Repair and Apoptosis by p53 and Its Impact on Alkylating Drug Resistance of Tumor Cells

  2004cites this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004influential citation